IXAZOMIB CITRATE |
NINLARO |
MLN-9708 |
FDA Approval | not approved |
Drug Class | Small molecule |
Drug Indications | antineoplastic agent |
inhibitor (inhibitory) |
Trial Name | MLN-9708 |
Novel drug target | Established target |
Mechanism of Interaction | 26S proteosome inhibitor |
inhibitor (inhibitory) |
Mechanism of Interaction | 26S proteosome inhibitor |
Direct Interaction | yes |
Trial Name | MLN-9708 |
inhibitor (inhibitory) |
Trial Name | MLN-9708 |
Novel drug target | Established target |
Mechanism of Interaction | 26S proteosome inhibitor |
inhibitor (inhibitory) |
Trial Name | MLN-9708 |
Novel drug target | Established target |
Mechanism of Interaction | 26S proteosome inhibitor |
inhibitor (inhibitory) |
Mechanism of Interaction | 26S proteosome inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | 26S proteosome inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | 26S proteosome inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | 26S proteosome inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | 26S proteosome inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | 26S proteosome inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | 26S proteosome inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | 26S proteosome inhibitor |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | 26S proteosome inhibitor |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | 26S proteosome inhibitor |
inhibitor (inhibitory) |
Mechanism of Interaction | 26S proteosome inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | 26S proteosome inhibitor |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | 26S proteosome inhibitor |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | 26S proteosome inhibitor |
inhibitor (inhibitory) |
Trial Name | MLN-9708 |
Novel drug target | Established target |
Mechanism of Interaction | 26S proteosome inhibitor |
inhibitor (inhibitory) |
Mechanism of Interaction | 26S proteosome inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | 26S proteosome inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | 26S proteosome inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | 26S proteosome inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | 26S proteosome inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | 26S proteosome inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | 26S proteosome inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | 26S proteosome inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | 26S proteosome inhibitor |
inhibitor (inhibitory) |
Mechanism of Interaction | 26S proteosome inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | 26S proteosome inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | 26S proteosome inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | 26S proteosome inhibitor |
inhibitor (inhibitory) |
Mechanism of Interaction | 26S proteosome inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | 26S proteosome inhibitor |
inhibitor (inhibitory) |
Mechanism of Interaction | 26S proteosome inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | 26S proteosome inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | 26S proteosome inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | 26S proteosome inhibitor |
Direct Interaction | yes |
Drug Indications | antineoplastic agent |
Drug Class | Small molecule |
FDA Approval | not approved |